Metformin Administration Versus Laparoscopic Ovarian Diathermy in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome: A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
At present, it is unclear what the role is of laparoscopic ovarian diathermy (LOD) and of metformin administration as second-line treatments for ovulation induction in women with polycystic ovary syndrome (PCOS) after failure of clomiphene citrate (CC) treatment. The aim of the present study was to compare in a randomized double-blind placebo-controlled fashion the effectiveness of LOD with metformin administration in the treatment of CC-resistant women with PCOS. A total of 120 overweight primary infertile anovulatory CC-resistant women with PCOS were enrolled and randomized into two groups of treatment. Group A underwent diagnostic laparoscopy, whereas group B underwent LOD. At hospital discharge, the patients were treated for 6 months with metformin cloridrate (group A; 850 mg twice daily) or with multivitamins (group B). The ovulation, pregnancy, abortion, and live-birth rates were evaluated. At the end of the study, the total ovulation rate was not statistically different between both treatment groups (54.8 vs. 53.2% [correction] in groups A and B, respectively), whereas the pregnancy (21.8 [correction] vs. 13.4%), the abortion (9.3 [correction] vs. 29.0%), and the live-birth (86.0 [correction] vs. 64.5%) rates were significantly (P < 0.05) different between the two groups. Our data show that metformin administration is more effective than LOD in overall reproductive outcomes in overweight infertile CC-resistant women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two medium-quality RCTs (level II) with moderate risk of bias found insufficient evidence to recommend laparoscopic ovarian surgery compared with metformin for live birth rate per patient, ovulation or pregnancy rate per cycle, pregnancy rate per patient and miscarriage rate per pregnancy. 257-259”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [258]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [94]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“None of the currently available human insulin preparations have been demonstrated to cross the placenta (93-98).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Cited by
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Farquhar, C., Brown, J., & Marjoribanks, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001122.pub4 · Cited by 456
Palomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Self-citation14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0110 · Cited by 279
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
The role of metformin in polycystic ovary syndrome: a systematic review
Moll, E., van der Veen, F., & van Wely, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm026 · Cited by 188
“Metformin as opposed to LOD Only one randomized trial was retrieved in which metformin treatment was compared with LOD (Table 1) (Palomba et al., 2004).”
InfluentialPenzias, A., Bendikson, K., Butts, S., Coutifaris, C., Falcone, T., Fossum, G., Gitlin, S., Gracia, C., Hansen, K., La Barbera, A., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.026 · Cited by 181
13. Management of Diabetes in Pregnancy
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s016 · Cited by 179
Cassina, M., Donà, M., Di Gianantonio, E., Litta, P., & Clementi, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu022 · Cited by 143
“…exposed to metformin prior to or during the first trimester of pregnancy; all of these publications were excluded from the meta-analysis since there was overlap with other studies or because data on birth defects were lacking (Palomba et al., 2004, 2005a, c, d, 2006, 2007, 2009a, 2010, 2011a, b).”
ResultOvulation induction: a mini review
Messinis, I. E. (2005) · Human Reproduction · doi:10.1093/humrep/dei128 · Cited by 140
“A recent randomized controlled trial (Palomba et al., 2004) has shown that metformin treatment for 6 months in overweight anovulatory infertile clomiphene-resistant PCOS patients induced an ovulation rate comparable to LOD (54.”
ResultInfluentialPregnancy complications in PCOS
Homburg, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.03.009 · Cited by 142
“Two further smaller trials compared, firstly, the use of metformin versus laparoscopic ovarian diathermy of the ovaries for clomiphene resistant PCOS women who were overweight [ 28 ] and then metformin versus clomiphene in non-obese anovulatory PCOS [29].”
ResultPalomba, S., Falbo, A. I., Orio, F., & Zullo, F. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.087 · Cited by 147
Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
Sharpe, A., Morley, L. C., Tang, T., Norman, R. J., & Balen, A. H. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013505 · Cited by 132
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
Dunaif, A. E. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0787 · Cited by 131
“A few RCTs have assessed pregnancy outcomes in PCOS”
BackgroundCostello, M. F., Misso, M. L., Balen, A., Boyle, J., Devoto, L., Garad, R. M., Hart, R., Johnson, L., Jordan, C., Legro, R. S., et al. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoy021 · Cited by 122
Insulin resistance and polycystic ovary syndrome
Galluzzo, A., Amato, M. C., & Giordano, C. S. D. S. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.05.004 · Cited by 137
Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02208.x · Cited by 119
Tan, S., Hahn, S., Benson, S., Dietz, T., Lahner, H., Moeller, L. C., Schmidt, M., Elsenbruch, S., Kimmig, R., Mann, K., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0294 · Cited by 112
Palomba, S., Falbo, A., Orio, F., Manguso, F., Russo, T., Tolino, A., Annamaria, C., Dale, B., & Zullo, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei130 · Cited by 106
“Both observational and randomized controlled trials (Harborne et al., 2003; Kashyap et al., 2004; Palomba et al., 2004b, 2005) have successively confirmed the effectiveness of metfomin in PCOS women in terms of menstrual Downloaded from…”
BackgroundMethodInfluential15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Bordewijk, E. M., Ng, K. Y. B., Rakic, L., Mol, B. W. J., Brown, J., Crawford, T. J., & van Wely, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001122.pub5 · Cited by 89
The treatment of infertility in polycystic ovary syndrome: a brief update
Costello, M. F., Misso, M. L., Wong, J., Hart, R., Rombauts, L., Melder, A., Norman, R. J., & Teede, H. J. (2012) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2012.01448.x · Cited by 86
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome
Palomba, S., Russo, T., Orio, F., Falbo, A., Manguso, F., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei351 · Cited by 85
“Recent randomized controlled trials (RCT) have shown that anovulatory women with PCOS who have restored ovulation after metformin treatment exhibited a surprisingly high reproductive potential, with lower-than-expected rate of spontaneous miscarriage (Palomba et al., 2004b, 2005a).”
BackgroundSelf-citationSun, Y., Zhang, J., Xu, Y., Cao, Z.-Y., Wang, Y.-Z., Hao, G., & Gao, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592495 · Cited by 98
A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage
Cocksedge, K. A., Li, T.-C., Saravelos, S. H., & Metwally, M. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60304-5 · Cited by 73
Nayak, P., Agrawal, S., & Mitra, S. (2015) · Journal of Natural Science, Biology and Medicine · doi:10.4103/0976-9668.149076 · Cited by 68
“Improvement in hormonal profi les does not translate into a comparable improvement in insulin sensitivity or reduction in risk of gestational diabetes mellitus (GDM).[10,14,61,78] Although patients with metabolic syndrome should not be precluded from LOD, adjuvant therapy with insulin sensitizers should be considered.”
BackgroundInfluentialLi, X.-J., Yu, Y.-X., Liu, C.-Q., Zhang, W., Zhang, H.-J., Yan, B., Wang, L.-Y., Yang, S.-Y., & Zhang, S.-H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03917.x · Cited by 67
Measuring outcomes in fertility trials: can we rely on clinical pregnancy rates?
Clarke, J., van Rumste, M. M. E., Farquhar, C. M., Johnson, N., Mol, B. W., & Herbison, P. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.018 · Cited by 66
Palomba, S., Falbo, A., Russo, T., Orio, F., Tolino, A., & Zullo, F. (2010) · Human Reproduction · doi:10.1093/humrep/dep466 · Cited by 67
“Thereafter, Groups A1 and B1 were treated with ovarian diathermy and myomectomy, respectively, according to standard procedures described previously (Palomba et al., 2004, 2007a).”
Polycystic ovarian syndrome – prognosis and outcomes
Hart, R. J., & Norman, R. J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.04.006 · Cited by 69
Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review
Fernandez, H., Morin-Surroca, M., Torre, A., Faivre, E., Deffieux, X., & Gervaise, A. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.03.013 · Cited by 68
Palomba, S., Falbo, A., & Zullo, F. (2009) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328332d188 · Cited by 61
Palomba, S., Orio, F., Falbo, A., Russo, T., Tolino, A., & Zullo, F. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.021 · Cited by 56
Self-citationThe Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
Katsiki, N., Georgiadou, E., & Hatzitolios, A. I. (2009) · Drugs · doi:10.2165/00003495-200969110-00001 · Cited by 57
Doldi, N., Persico, P., Sebastiano, F. D., Marsiglio, E., & Ferrari, A. G. (2006) · Gynecological Endocrinology · doi:10.1080/14767050600761893 · Cited by 52
Polycystic Ovary Syndrome and the Metabolic Syndrome
Sharpless, J. L. (2003) · Clinical Diabetes · doi:10.2337/diaclin.21.4.154 · Cited by 57
Fertility in Polycystic Ovary Syndrome
Patel, S. M., & Nestler, J. E. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.09.005 · Cited by 54
Palomba, S., Orio, F., Falbo, A. I., Russo, T., Tolino, A., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.035 · Cited by 50
Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?
Hashim, H. A. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.09.015 · Cited by 54
Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells
Germeyer, A., Jauckus, J., Zorn, M., Tóth, B., Capp, E., & Strowitzki, T. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.11.006 · Cited by 49
“However, it was not possible to determine if this was due to a positive effect on the oocyte quality or due to endometrial effects (Palomba et al., 2004, 2005) as metformin seems to improve the endometrial thickness and blood flow in PCO women with prior anovulatory cycles (Palomba et al., 2006).”
BackgroundAbdellah, M. S. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.11.026 · Cited by 41
RetractedHamed, H. O., Hasan, A. F., Ahmed, O. G., & Ahmed, M. A. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.033 · Cited by 41
“In the first study [11], no significant difference was found in the ovulation or pregnancy rates between patients who received metformin or LOD; however, the second study reported a higher pregnancy rate in the metformin group [12].”
BackgroundMethodResultInfluentialRetractedHurst, B. S., Hickman, J. M., Matthews, M. L., Usadi, R., & Marshburn, P. B. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.10.031 · Cited by 46
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 53
“ized controlled trials (RCT) showed this positive effect of metformin therapy on endocrine and metabolic variables, not only in obese or insulin-resistant PCOS patients, but even in lean and insulin-sensitive women [27–31].”
BackgroundMetformin—Comparison with Other Therapies in Ovulation Induction in Polycystic Ovary Syndrome
Norman, R. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1658 · Cited by 38
Second World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1821 · Cited by 36
“A study (80) comparing metformin with laparoscopic ovarian drilling in clomiphene-resistant women with PCOS showed similar ovulation rates of 55 vs.”
BackgroundHashim, H. A., Foda, O., & Ghayaty, E. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12673 · Cited by 42
“Four trials were excluded for the following reasons: one study was a prospective study but not an RCT (31); another study was a prospective quasi-randomized trial (32); sensitivity to clomiphene was not reported in one RCT (33); one RCT compared metformin with LOD for six cycles with addition of clomiphene after the e…”
BackgroundPatient-tailored conventional ovulation induction algorithms in anovulatory infertility
van Santbrink, E. J. P., Eijkemans, M. J. C., Laven, J. S. E., & Fauser, B. C. J. M. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.08.006 · Cited by 38
Dasari, P., & Pranahita, G. (2009) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.51337 · Cited by 42
“Batukan[9] found an abortion rate of 20% and Palomba[17] 15% when CC and metformin was used for ovulation induction.”
Polycystic ovarian syndrome – prognosis and treatment outcomes
Hart, R. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f10e22 · Cited by 34
Palomba, S., Falbo, A., Battista, L., Russo, T., Venturella, R., Tolino, A., Orio, F., & Zullo, F. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.11.042 · Cited by 33
Self-citationIs metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Cheang, K. I., Sharma, S. T., & Nestler, J. E. (2006) · Gynecological Endocrinology · doi:10.1080/09513590601005847 · Cited by 32
“Sixty women underwent a mock laparoscopy and then took metformin 850 mg twice daily for 6 months, and 60 women underwent laparoscopic ovarian diathermy and then took placebo (multivitamins) for 6 months [36].”
MethodResultPalomba, S., Orio, F., Falbo, A. I., Russo, T., Caterina, G., Manguso, F., Tolino, A., Colao, A., & Zullo, F. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02392.x · Cited by 34
Ovulation induction in normogonadotropic anovulation (PCOS)
van Santbrink, E. J. P., & Fauser, B. C. J. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.03.002 · Cited by 30
Costello, M., Garad, R. M., Hart, R. J., Homer, H. A., Johnson, L., Jordan, C., Mocanu, E. V., Qiao, J., Rombauts, L. J. F., Teede, H. J., et al. (2019) · Medical Sciences · doi:10.3390/medsci7070075 · Cited by 31
“There are two RCTs that compare LOS versus metformin in clomiphene-citrate-resistant women with PCOS which show conflicting findings [30,31].”
BackgroundOvulation induction in women with polycystic ovary syndrome
Palomba, S., Orio, F., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.018 · Cited by 33
Hashim, H. A., El-lakkany, N., & Sherief, L. S. (2010) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2010.01383.x · Cited by 29
“Aromatase inhibitors, such as letrozole, have attracted attention as promising drugs that could challenge CC for ovulation induction in anovulatory women with PCOS.”
MethodInfluentialImpact of androgens on fertility – physiological, clinical and therapeutic aspects
Hugues, J., & Cédrin‐Durnerin, I. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61165-0 · Cited by 30
Mohsen, I. A., ElKattan, E. A., Nabil, H., & Khattab, S. (2012) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22006 · Cited by 26
Yuan, L., Wu, H., Huang, W., Bi, Y., Qin, A., & Yang, Y. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00772-7 · Cited by 25
The Polycystic Ovary Syndrome: Current Concepts On Pathogenesis And Clinical Care
Azziz, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7 · Cited by 29
Letrozole for patients with polycystic ovary syndrome: A retrospective study
Guang, H.-J., Li, F., & Shi, J. (2018) · Medicine · doi:10.1097/md.0000000000013038 · Cited by 38
“3%.([32]) Thus, the desired sample size for each group was estimated to be 68 patients with 25% difference between 2 groups, and a power of 80% in this study.”
BackgroundPolycystic Ovarian Syndrome Management Options
Bates, G. W., & Propst, A. M. (2012) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2012.10.001 · Cited by 25
Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome
Palomba, S., Falbo, A. I., Orio, F., Russo, T., Tolino, A., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.063 · Cited by 22
Yu, Y., Fang, L., Zhang, R., He, J., Xiong, Y., Guo, X., Du, Q., Huang, Y., & Sun, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03803-9 · Cited by 25
Leeman, L., & Acharya, U. (2009) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610902829414 · Cited by 22
“This study made the recommendation that metformin be administered for a period of 6 months before adding CC to the regime in CC-resistant patients (Palomba et al. 2004).”
BackgroundHayashi, H., Ezaki, K., Endo, H., & Urashima, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500424214 · Cited by 20
“for overweight, infertile, CC-resistant women with PCOS [12].”
BackgroundHashim, H. A., Foda, O., Ghayaty, E., & Elawa, A. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1983-x · Cited by 19
“[27], but less than that (30%) was reported by Amer et al.”
BackgroundRetractedLiu, K. E., TATARYN, I. V., & Sagle, M. A. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32202-2 · Cited by 18
Cheshire, J., Garg, A., Smith, P., Devall, A., Coomarasamy, A., & Dhillon‐Smith, R. K. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.05.038 · Cited by 20
Costello, M., & Ledger, W. J. (2012) · Women s Health · doi:10.2217/whe.12.7 · Cited by 18
Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients
Palomba, S., Falbo, A. I., Orio, F., & Zullo, F. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328307ebc5 · Cited by 18
Polycystic ovary syndrome and metformin in pregnancy
Lilja, A. E., & Mathiesen, E. R. (2006) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340600780441 · Cited by 18
“However, pregnancy and live-birth rates have been found to be significantly higher following metformin treatment, rather than ovarian drilling (26).”
BackgroundSurgical treatment in polycystic ovary syndrome
Ünlü, C., & Atabekoğlu, C. S. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000193020.82814.9d · Cited by 18
Strowitzki, T., & von Wolff, M. (2005) · Gynecological Surgery · doi:10.1007/s10397-005-0099-3 · Cited by 15
“Palomba et al. [ 45 ] Prospective randomised 54 metformin 54.8% 18.6% 59% 3–6 Monopolar 40 W 55 LOD 53.3% per cycle 13.4% per cycle 36% per patients”
BackgroundMethodInfluentialAshrafinia, M., Hosseini, R., Moini, A., Eslami, B., & Asgari, Z. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.06.022 · Cited by 15
“Two studies that compared treatment with metformin with laparoscopic ovarian diathermy (LOD) in patients resistant to clomiphene citrate (CC) [10,11] produced conflicting results.”
BackgroundResultKong, G. W. S., Cheung, L. P., & Lok, I. H. (2011) · PubMed · Cited by 15
Metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview
Palomba, S., Oppedisano, R., Tolino, A., Orio, F., & Zullo, F. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60592-5 · Cited by 18
Capp, E., Jauckus, J., Corleta, H. V. E., Tóth, B., Strowitzki, T., & Germeyer, A. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.05.012 · Cited by 12
“Even though positive effects of metformin on implantation and pregnancy rates are shown, the pathophysiologic mechanisms are unknown and we can only speculate that folliculogenesis, as well as endometrial receptivity are ameliorated [3,4].”
BackgroundAdropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse
Maurya, S., Tripathi, S., Arora, T. K., & Singh, A. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-93215-x · Cited by 14
“Moreover, metformin therapy has been shown to effectively restore ovulation, regulate the menstrual cycle, and alleviate hirsutism, thus playing a crucial role in the management of PCOS 11,50 .”
Gibreel, A., Ali, R., Hemida, R., Sherif, L., & Eladawi, N. (2019) · Middle East Fertility Society Journal · doi:10.1186/s43043-019-0001-2 · Cited by 13
“Polycystic ovarian syndrome is the most common cause of anovulatory subfertility [1].”
BackgroundPalomba, S., Falbo, A. I., Orio, F., Russo, T., Sbano, F. M., D’Alessandro, P., Cariati, F., Tolino, A., Colao, A., & Zullo, F. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600645700 · Cited by 13
“Although LOD has been proposed as a first- [4], second- [5] and third-line [6] option in the treatment of anovulatory PCOS women, evidence confirms the role of LOD as an efficacious second-line treatment in CC-resistant women [7].”
BackgroundManagement of Infertility in Women with Polycystic Ovary Syndrome: A Practical Guide
Stadtmauer, L., & Oehninger, S. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504050-00002 · Cited by 17
Effect of DHEA and metformin on corpus luteum in mice
Sander, V. A., Facorro, G. B., Piehl, L. L., de Celis, E. R., & Motta, A. B. (2009) · Reproduction · doi:10.1530/rep-08-0325 · Cited by 11
“While Meenakumari et al. (2004) demonstrated that metformin restores P levels during the functional stage of CL development in PCOS patients, Vrbı́ková et al. (2001) reported no significant changes in basal steroid production.”
BackgroundInfluentialHamed, H. O. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12101 · Cited by 12
The role of metformin in ovulation induction: Current status
Elnashar, A. M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.003 · Cited by 14
The use of insulin sensitising agents in ovulation induction in women with Polycystic Ovary Syndrome
Fleming, R. (2006) · HORMONES · doi:10.14310/horm.2002.11181 · Cited by 14
“However, more encouraging results, in a relatively lean cohort, were obtained by comparison with the effect of laparoscopic ovarian diathermy, showing that metformin was at least as effective in terms of achieving pregnancy within 6 months.(28)”
ResultLe syndrome des ovaires polykystiques (SOPK)
Torre, A., & Fernandez, H. (2007) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2007.04.002 · Cited by 23
Pregnancy Complications in PCOS
Homburg, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_11 · Cited by 11
Treatment for polycystic ovary syndrome: a critical appraisal of treatment options
Nader, S. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.3.349 · Cited by 9
Metadata
- Authors
- Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., & Zullo, F.
- Affiliations
- Magna Graecia University (IT)
- St Mary's Hospital (GB)
- Federico II University Hospital (IT)
- Corresponding author
- Palomba, Stefano
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-10
- Volume
- 89
- Issue
- 10
- Pages
- 4801-4809
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2113943040
- Cited by
- 177
- References
- 86
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2022: 7 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 8
- FWCI
- 20.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- metformin, polycystic ovary syndrome, clomiphene citrate resistance, ovulation induction, anovulatory infertility, pregnancy rate, live birth rate, abortion rates, ovulation rate, overweight women
- MeSH terms
- Adult, Ambulatory Surgical Procedures, Clomiphene, Double-Blind Method, Drug Resistance, Electrocoagulation, Female, Fertility Agents, Female, Humans, Hypoglycemic Agents, Metformin, Patient Dropouts, Laparoscopy, Placebos, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Outcome, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.